drugset
drugset / Trial / NCT01333696

Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck

NCT01333696 ↗

Phase 2 Unknown 32 enrolled Fudan University
NaSingle-groupOpen-labelTreatment

Summary

The aim of the study is to evaluate the efficacy and safety of pemetrexed monotherapy as salvage treatment in patients with relapsed or metastatic squamous cell carcinoma of head and neck.

Timeline

Start
2011-04
Primary completion
2013-04
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Pemetrexed Small molecule 500 mg/m2 —

Indications

head and neck squamous cell carcinoma